SARS-CoV-2 (COVID-19) has taken the world by storm. The most common clinical features reported at the onset of COVID-19 include Cough (79.4%), fever (77.1%), dyspnea (56.5%), myalgias (23.8%), diarrhea (23.7%), and nausea/vomiting (19.1%).
Once a patient is tested positive for COVID-19, they are developing ARDS, cardiovascular complications, kidney failure, and brain stroke. A high prevalence of diabetes, obesity, hypertension are reported in severe COVID-19 cases. So it would be recommended to isolate those people who are at-risk or patients of these co-morbidities as they will mostly develop complications of COVID-19. Thermal cameras have been widely used in this pandemic for fever screening. However, our solutions use thermal patterns on the face and extract a bio-signal that has information related to the mentioned co-morbidities. Also, our technology gives fever indication, shortness of breath, loss of oxygen to tissues with the same thermal camera screening.
Using our technology, we are able to differentiate patients who are at an increased rate of complications and mortality in a no-contact, no-radiation method. Also, people who are at risk of developing these co-morbidities may be identified as a higher risk group for contacting COVID-19 in general population screening. Our comorbidity algorithms are medically reviewed, peer-published, and already launched in the market.
PreDxCOVID is our solution developed exclusively for COVID-19 screenings. It is easy to use, portable, and produces real-time results. It provides screening for symptoms such as fever, shortness of breath, hypoxia, etc. If you are interested in screening teams for COVID-19 for all symptoms (& not just fever), PreDxCOVID is your solution!